Chronic Kidney Disease, Diabetes, Atherosclerosis, Alzheimer's disease. Vitae Pharmaceuticals Inc.
Description
pulled from site's meta descriptionVitae Pharmaceuticals is a clinical stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large market opportunities, including chronic kidney disease, diabetes, atherosclerosis and Alzheimer's disease.
This is an automatically generated AboutUs page for VitaEpharMa.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- Vitae Pharmaceuticals
- Vitae
- CONTOUR
- CONTOUR platform
- CONTOUR technology
- structure-based drug design
- Structural Biology
- chronic kidney disease
- CKD
- diabetes
- atherosclerosis
- Alzheimer's disease
- Renin Inhibitor
- 11ß HSD-1 Inhibitor
- BACE Inhibitor
- VTP-27999
- LXR
- ApoE
- LXR modulator
- reverse cholesterol transport
- lxr dermatology
- alzheimer's
- partnering
- partnerships
- dermatology
- derm
- ror
- ror gamma
- ror inhibitor
- ror gamma inhibitor
- autoimmune
- autoimmune disease